CatalystWireBeta

UK small-cap RNS · 28 Apr 2026

Every announcement of UK small & mid caps under £2bn. The ones that started or moved a situation are marked – a click opens it.

Sort: Newest · Largest companies
  1. 16:40
    Director/PDMR Shareholding Director dealing
  2. 12:56
    Audited Accounts to 31 December 2025 & Suspension
    The audit delay from the Fibermode wind-down means FY25 results miss the 30 April deadline, so the shares are suspended from 1 May until the results are published. Shareholders cannot trade in the meantime.
    Moved: Wind-down and search for acquisition: Wind-down continues; acquisition search ongoing → Fibermode wind-down delaying FY25 audit
  3. 11:49
    Holding(s) in Company Holding
  4. 09:11
    Final Results Results
    Final results show a US$4.98m loss, narrower than 2024's US$5.30m, despite impairments and a warrant loss. The company is debt-free and carried to first gas, but has no revenue until Ntorya starts.
    Project milestones outlook positivefirst in 7 months +0.0% on the day
    Moved: Ntorya gas field development: Pre-construction; contracts and tenders advancing → Pipeline under construction; CH-1 drilling preparations
  5. 07:00
    Eco Buildings Delivers Balfin Milestone
    Eco Buildings Delivers Major Balfin Milestone as Scalable Housing Platform Gains Momentum
    Project milestones outlook positive +1.9% on the day
    Moved: new: Rolling Hills Balfin apartment blocks – First block built to ground floor; walls in stock
  6. 07:00
    FDA Fast Track Designation for iSCIB1+
    Scancell receives FDA Fast Track Designation for iSCIB1+ in advanced melanoma and provides data update from its SCOPE Phase 2 study
    Project milestones outlook positive +5.8% on the day
    Moved: iSCIB1+ melanoma registration path: IND cleared; financing and partnering talks ongoing → IND cleared, Fast Track granted; financing unsecured
  7. 07:00
    Final Results Results
    2025 free cash flow ($99m) missed expectations on late revenue and delayed Kenya and Ghana receipts, and production was at the low end. Q1 2026 is strong and guidance is raised.
    Legal & regulatory in lineoutlook positive, raisedfirst in 8 months +11.4% on the day
    Moved: Year-end 2024 net debt below $1.4bn and gearing about 1x: pending → missed – Year-end 2024 net debt was $1,452m with gearing of 1.4x, against the target of below $1.4bn and about 1x. · Cut annual cash net G&A by about $10m to about $40m in 2025: on_track → missed – 2025 net G&A fell to c.$45m from c.$52m, a smaller cut than the c.$10m to about $40m targeted. · Jubilee drilling and seismic programme: Four-well programme targeted for 2026 → J74-P and J75-P onstream; four wells to come
  8. 07:00
    Final Results Results
    Audited 2025 results confirm the January beat: revenue, recurring revenue, adjusted profit and cash all ahead of market expectations. Statutory profit falls on the £2.3m Veeuze impairment.
    Disposal of a part (break-up) ahead of expectationsoutlook positivefirst in 7 months +3.7% on the day
    Moved: Veeuze disposal and financing: Agreed; €1.5m loan to buyer outstanding → Sold to management buy-out; impairment booked in FY2025 · Kivue integration and PPM growth: Acquisition completed; integration under way → Acquired Feb 2026; merging with BestOutcome
  9. 07:00
    1st Quarter Results Results
    Private large portfolio companies grew EBITDA 26.9% and revenue 13.7%, but NAV per share was flat in GEL as a flat LFG share price and a renewable write-down offset gains. Post-quarter LFG rally lifts NAV 9.2% YTD.
    Capital return outlook positive −3.2% on the day
    Moved: GEL 700m capital return programme: US$50m tranche completed; new US$50m launched → Second US$50m buyback under way; 475,000 shares bought in 1Q26

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note